KaydedilenlerDerginizi ekleyin

Dergiler / Sakarya University Journal of Science / 2022 / Cilt: 26 Sayı: 5

Conformational Analysis and DFT Investigations of 1-(4-Fluorophenyl)Piperazine by ELF and LOL, Inhibitory activity against Alzheimer’s Disease, and ADME Prediction

Sibel ÇELİK
Sayfa
931–941
Yayın Tarihi
2022-10-20
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The docking predicts the possibility of a potential drug to improve Alzheimer's disease (AD) treatment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study reports 1-(4-Fluorophenyl)Piperazine molecule structural and electronic properties calculated at the DFT/B3LYP level.
📊
Temel Bulgular & Veri:A potential energy surface scan along the rotational bonds discovered the most stable minimum energy conformer of the title compound.
💡
Sonuç & Katkı:The docking predicts the possibility of a potential drug to improve Alzheimer's disease (AD) treatment.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:1-(4-Fluorophenyl)Piperazine · DFT · ADME

Abstract

This study reports 1-(4-Fluorophenyl)Piperazine molecule structural and electronic properties calculated at the DFT/B3LYP level. A potential energy surface scan along the rotational bonds discovered the most stable minimum energy conformer of the title compound. Frontier molecular orbital (FMO) analyses, density of state (DOS), molecular electrostatic potential (MEP), and global and chemical reactivity descriptors were also used to investigate the reactivity of the pFPP molecule. In addition, ELF and LOL analysis were performed. In silico biological studies such as drug-likeness, ADME, and toxicity properties were also performed. Molecular docking studies are performed to predict the anti-Alzheimer agent enzyme (AChE) active site of the pFPP. The docking predicts the possibility of a potential drug to improve Alzheimer's disease (AD) treatment.

🔖

Bu Makaleye Atıf Yap

ÇELİK, S. (2022). Conformational Analysis and DFT Investigations of 1-(4-Fluorophenyl)Piperazine by ELF and LOL, Inhibitory activity against Alzheimer’s Disease, and ADME Prediction. Sakarya University Journal of Science, Cilt: 26 Sayı: 5, 931–941. https://ajindex.com/articles/940548

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. D. Y. Peng, Q. Sun, X. L. Zhu, H. Y. Lin, Q. Chen, N. X. Yu, W. C. Yang, G. F. Yang, “Design, synthesis, and bioevaluation of benzamides: Novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase,’’ Bioorganic Medicinal Chemistry, vol. 20, pp. 6739-6750, 2012
  2. Q. Sun, D. Y. Peng, S. G. Yang, X. L. Zhu, W. C. Yang, G. F. Yang, “Syntheses of coumarin–tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase,” Bioorganic Medicinal Chemistry, vol. 22, pp. 4784-4791, 2014
  3. K. S. T. Diasa, C. Viegas, “Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease,” Current Neuropharmacology, vol. 12, pp. 239-255, 2014
  4. E. M. H. Brewton, E. M. Hersh, G. Brewton, D. Abrams, J. Bartlett, J. Galpin, P. Gill, R. Gorter, M. Gottlieb, J. J. Jonikas, S. Landesman, A. Levine, A. Marcel, E. A. Petersen, M.Whiteside, J. Zahradnik, C. Negron, F. Boutitie, J. Caraux, J.-M. Dupuy, L. R. Salmi, “Dithiocarbsodium(diethyldithiocarbamate) therapy in patients with symptomatic HIV-infection. Aids a randomized, double-blind, placebo-controlled multicenter study, ” American Medical Association, vol. 265, pp. 1538–1544, 1991
  5. C. B. Mishra, A. Manral, S. Kumari, V. Saini, M. Tiwari, “Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-bamyloid aggregation, antioxidant and neuroprotection properties against Alzheimer’s disease,’’ Bioorganic Medicinal Chemistry, vol. 24, pp. 3829–384, 2016
  6. H. S. N. Prasada, A.P. Ananda, T.N. Lohithd, P. Prabhuprasad, H.S. Jayanth, N.B. Krishnamurthy, M.A. Sridhar, L. Mallesha, P. Mallu, “Design, synthesis, molecular docking and DFT computational insight on the structure of Piperazine sulfynol derivatives as a new antibacterial contender against superbugs MRSA,’’ Journal of Molecular Structure, vol. 1247, 131333, 2022
  7. S. B. Ozdemir, N. Demirbas, A. Demirbas, N. Colak, F.A. Ayaz, “Design, Microwave-Assisted and Conventional Synthesis of New Hybrid Compounds Derived From 1-(4-Fluorophenyl) piperazine and Screening for Their Biological Activities,’’ ChemistrySelect 3, pp. 2144 – 2151, 2018
  8. A. Alzheimer, “Alzheimer's disease facts and figures,’’ Alzheimer's & dementia: The Journal of the Alzheimer's Association, vol. 11, pp. 332-384, 2015
  9. D. Scherman, M. Hamon